Hip osteoarthritis, n = 28 | Control group, n = 21 | Statistical difference between groups, p | |
---|---|---|---|
Female, n (%) | 18 (64) | 13 (62) | 0.864 |
Age, years, mean (SD) | 66.0 (9.0) | 66.2 (9.7) | 0.948 |
Height (cm), mean (SD) | 170 (9.0) | 171 (8.0) | 0.743 |
Weight (kg), mean (SD) | 76.3 (16.0) | 72.6 (12.5) | 0.386 |
BMI (m2/kg), mean (SD) | 26.2 (4.2) | 24.8 (3.0) | 0.184 |
Symptom duration, years, median (range) | 3.5 (0.5–12.5) | – | |
Kellgren Lawrence grade (1–4b) | |||
1–2 | – | – | |
3a,n (%) | 2 (7) | – | |
3b,n (%) | 7 (25) | – | |
4a,n (%) | 10 (36) | – | |
4b,n (%) | 9 (32) | – | |
Hip osteoarthritis outcome score (0–100) | |||
Pain | 44 (11) | 98 (4) | < 0.001 |
Symptoms | 40 (16) | 96 (5) | < 0.001 |
ADL | 49 (14) | 97 (7) | < 0.001 |
Sport and recreation | 29 (18) | 96 (10) | < 0.001 |
Hip-related quality of life | 27 (13) | 95 (9) | < 0.001 |